Photo from Patrick Forde/Twitter
Sep 20, 2023, 17:07
Patrick Forde: Results of 1st platform neoadjuvant IO trial in lung cancer led by Dr. Tina Cascone!
Quoting Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies on X/Twitter:
”Results of 1st platform neoadjuvant IO trial in lung cancer led by Dr. Tina Cascone! We believe this trial design and in depth science will deliver valuable and rapid info to prioritize new IO agents in early and late stage cancer. NeoCOAST2 already underway!”
For the information click here.
Source: Patrick Forde/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19